Webinar | October 23rd 2025

Obesity and diabetes—two of the most widespread and interrelated health challenges of our time.

According to the World Obesity Atlas 2025, over 1 billion adults globally are projected to be living with obesity by 2030, with nearly half of the world’s population affected by overweight or obesity.

1. Obesity is a major risk factor for type 2 diabetes, which has seen a four-fold increase in global prevalence since 1980, now affecting over 500 million people worldwide.

2. These conditions are not only clinical concerns—they are also deeply systemic, contributing to rising healthcare costs, increased morbidity, and reduced quality of life. Yet, both are largely preventable and manageable with the right strategies.

• The evolving epidemiology of obesity and diabetes,
• The importance of early intervention and integrated care pathways,
• And how healthcare systems can adapt to better support prevention, treatment, and long-term management.
• The role of multidisciplinary collaboration, digital tools, and patient-centered approaches in improving outcomes and reducing the burden of chronic disease.

We’ll also highlight that one of the key advantages of implementing this integrated care model is its low logistical complexity and operational simplicity. The approach emphasizes digital engagement, lifestyle coaching, and point-of-care testing—requiring minimal investment in heavy laboratory infrastructure or high-maintenance equipment. This enables scalable deployment across primary care settings, community clinics, and even remote areas, making it both cost-effective and operationally feasible for healthcare systems of varying capacities.
Join us to deepen your understanding and help shape a more proactive, coordinated response to obesity and diabetes—ensuring better care for patients and more sustainable healthcare systems.



Scientific Programme

(Time zone CET)

Moderators: A. Roncacci & A. Brown
18.00pm – Welcome & Opening | A. Roncacci & R. Santos
18.05pm – Redefining Metabolic Care: From Obesity Science to GLP-1 Therapeutics | L. Falvey and M. Ippolito
18.35pm – Multimorbidity in a diabetic patient| E. Suke
18.55pm – Τhe evolving Landscape of Diabetes-Overview of the latest updates | P. Katsogiannos
19.15pm – Q&A
19.35pm - Closing remarks | R. Santos



Expected Education Outcomes

• Understand the complex relationship between obesity and diabetes, including pathophysiology and epidemiology.
• Recognize evidence-based diagnostic criteria and screening tools for both conditions.
• Evaluate current therapeutic strategies and emerging treatment options tailored for patients with obesity and diabetes.
• Identify common complications associated with diabetes and obesity and develop effective prevention and management plans.
• Enhance collaboration among healthcare providers to deliver coordinated, patient-centered care, by applying the latest clinical guidelines and best practices.
• Implement an integrated care model to improve patient outcomes across multidisciplinary teams.
• Apply the latest clinical guidelines and best practices in obesity and diabetes management within the framework of the Affidea care model.



CME Information

The Scaling Impact: A Model for Obesity and Diabetes Care Across Affidea, Virtual, Netherlands 23/10/2025 - 23/10/2025 , has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.



Registrations



 

Target Audience

- Doctors from every medical specialty who deal with obesity and diabetes;
- Residents;
- Other healthcare professionals with an interest in this field – Lab Technicians, Nurses.



Faculty

Alessandro Roncacci, Radiologist, Senior Vice President CMO | Affidea Group
Adrian Brown, NIHR Advanced Fellow and Associate Professor (Principal Research Fellow) in Nutrition and Dietetics at the Centre of Obesity Research at University College London (UCL), which he co-leads. With over 19 years of clinical experience, he is a Senior Specialist Weight Management and Bariatric Dietitian and holds a PhD in Medicine from Imperial College London | London, England
Elena Šukė, MD. Chief Country GP | Affidea Lithuania
Laura Falvey, MBBS BSc, Executive Clinical Director Reset Health Ltd | UK
Mirko Ippolito, Medical Doctor, Specialist in Nutrition Science, with Clinical and Sports Dietetics Expertise. | Milano, Italy
Petros Katsogiannos, MD, PhD, Endocrinologist | Affidea Greece
Rosana Santos, Radiologist, Clinical Education Scientific Leader | Affidea Group




Organizing Committee:

Rosana Santos Clinical Education Scientific Leader, Affidea Group




Previous Webinars:

Challenges in Prostate Cancer: Screening and early Diagnosis
Expanding Teleradiology across Affidea
Critical Findings in Thoracic Imaging: expect the unexpected
Liver Imaging Update
The key to succeed in the Lab: Pre-Analytical Phase
Contrast Agents in Diagnostic Imaging: Myths and Truths - Iodine & Gadolinium
Critical Findings in Abdominal Imaging: expect the unexpected
Update on Breast Care
Clinical Research as a Care Option
Unlocking Dermatology: Strategies for identifying Skin Lesions and Building a Succcessful Dermatology Practice
The Deep Dive with Experts in Prostate Cancer - Integrated Diagnosis
MRI Safety Bridging Theory & Practice


Courses:

MRI Cardiac Course 2nd edition
Advanced Ultrasound Course